Literature DB >> 8944275

Features of recrudescent chloroquine-resistant Plasmodium falciparum infections confer a survival advantage on parasites and have implications for disease control.

S M Handunnetti1, D M Gunewardena, P P Pathirana, K Ekanayake, S Weerasinghe, K N Mendis.   

Abstract

This paper reports on the features of recrudescent infections of chloroquine-resistant Plasmodium falciparum (CQRPf) malaria from a study in vivo of patients from a malaria endemic (n = 527) and non-endemic (n = 129) region of Sri Lanka where the incidence of RI resistance was 30% and 55%, respectively. In both groups of patients, the recrudescent infections which emerged after treatment of the primary infection with chloroquine (CQ) and primaquine had significantly lower peripheral parasitaemia (0.036% and 0.108% in endemic and non-endemic patients, respectively) compared to their primary infections (mean parasitaemia 0.13% and 0.49%; P = 0.021 and 0.002, respectively). The recrudescences of CQ resistant infections also gave rise to clinical disease of markedly reduced severity (average clinical scores of 10.1 and 8.2) compared to their primary infections (average clinical scores of 12.4 and 12.3; P = 0.003 and 0.001, respectively, in endemic and non-endemic patients). CQ resistant recrudescent infections therefore had a lower probability of being diagnosed and treated. In endemic patients, a higher proportion of CQRPf infections (57%) had gametocytaemia compared to the chloroquine sensitive ones (29%) (P = 0.014, chi 2 = 5.96) and were significantly more infective to mosquitoes (P = 0.047). these findings imply that, in areas where CQ resistance is prevalent, the continued use of the drug may confer a survival and propagation advantage on resistant parasites and favour the rapid expansion of their reservoir. In support of this, we also present epidemiological evidence showing that, in endemic areas, the proportion of P. falciparum patients carrying gametocytes has increased significantly since the emergence of chloroquine resistance. These findings are relevant to the management of drug resistance and malaria control in countries where P.falciparum is only partially resistant to CQ.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8944275     DOI: 10.1016/s0035-9203(96)90325-9

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  15 in total

1.  Evidence that mutant PfCRT facilitates the transmission to mosquitoes of chloroquine-treated Plasmodium gametocytes.

Authors:  Andrea Ecker; Viswanathan Lakshmanan; Photini Sinnis; Isabelle Coppens; David A Fidock
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

2.  Persistent ICT malaria P.f/P.v panmalarial and HRP2 antigen reactivity after treatment of Plasmodium falciparum malaria is associated with gametocytemia and results in false-positive diagnoses of Plasmodium vivax in convalescence.

Authors:  E Tjitra; S Suprianto; J McBroom; B J Currie; N M Anstey
Journal:  J Clin Microbiol       Date:  2001-03       Impact factor: 5.948

3.  High prevalence of markers for sulfadoxine and pyrimethamine resistance in Plasmodium falciparum in the absence of drug pressure in the Ashanti region of Ghana.

Authors:  Florian Marks; Jennifer Evans; Christian G Meyer; Edmund N Browne; Christa Flessner; Vera von Kalckreuth; Teunis A Eggelte; Rolf D Horstmann; Jürgen May
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

Review 4.  Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Clin Microbiol Rev       Date:  2011-04       Impact factor: 26.132

5.  Adaptive changes in Plasmodium transmission strategies following chloroquine chemotherapy.

Authors:  A G Buckling; L H Taylor; J M Carlton; A F Read
Journal:  Proc Biol Sci       Date:  1997-04-22       Impact factor: 5.349

Review 6.  Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination.

Authors:  Rashad Abdul-Ghani; John C Beier
Journal:  Parasitol Res       Date:  2014-09-04       Impact factor: 2.289

Review 7.  Current status of malaria and potential for control.

Authors:  R S Phillips
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

8.  Mutations in cytochrome b resulting in atovaquone resistance are associated with loss of fitness in Plasmodium falciparum.

Authors:  Jennifer M Peters; Nanhua Chen; Michelle Gatton; Michael Korsinczky; Elizabeth V Fowler; Sergio Manzetti; Allan Saul; Qin Cheng
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

9.  Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes.

Authors:  Rachel L Hallett; Colin J Sutherland; Neal Alexander; Rosalynn Ord; Musa Jawara; Chris J Drakeley; Margaret Pinder; Gijs Walraven; Geoffrey A T Targett; Ali Alloueche
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

10.  Epochal changes in the association between malaria epidemics and El Niño in Sri Lanka.

Authors:  Lareef Zubair; Gawrie N Galappaththy; Hyemin Yang; Janaki Chandimala; Zeenas Yahiya; Priyanie Amerasinghe; Neil Ward; Stephen J Connor
Journal:  Malar J       Date:  2008-07-24       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.